The selectivity of protein kinase inhibitors: a further update - Test2 - elhamkhani - TriplyDB

The selectivity of protein kinase inhibitors: a further update

The selectivity of protein kinase inhibitors: a further update

http://www.wikidata.org/entity/Q24654622

about

MEK inhibitor U0126 reverses protection of axons from Wallerian degeneration independently of MEK-ERK signaling Tcf3 represses Wnt-β-catenin signaling and maintains neural stem cell population during neocortical development Structure prediction and validation of the ERK8 kinase domain GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS Regulation of miRNA transcription in macrophages in response to Candida albicans DYRK1A, a novel determinant of the methionine-homocysteine cycle in different mouse models overexpressing this Down-syndrome-associated kinase Molecular mechanism of action of metformin: old or new insights?Reproducibility and cell biology Phosphorylation of microtubule-associated protein tau by AMPK-related kinases Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65 Analysis of substrate specificity and cyclin Y binding of PCTAIRE-1 kinase Direct association of Sprouty-related protein with an EVH1 domain (SPRED) 1 or SPRED2 with DYRK1A modifies substrate/kinase interactions Mechanisms of STAT protein activation by oncogenic KIT mutants in neoplastic mast cells Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein Glycogen synthase kinase-3β is a crucial mediator of signal-induced RelB degradation Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1 Myocilin stimulates osteogenic differentiation of mesenchymal stem cells through mitogen-activated protein kinase signaling AMP-activated protein kinase, stress responses and cardiovascular diseases Evidence for irreversible inhibition of glycogen synthase kinase-3β by tideglusib The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice Raf-1: a novel cardiac troponin T kinase Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases Rapamycin and mTOR kinase inhibitors JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships The Role of p38 MAPK in the Development of Diabetic Cardiomyopathy p38 MAPK Signaling in Osteoblast Differentiation p38γ and p38δ Mitogen Activated Protein Kinases (MAPKs), New Stars in the MAPK Galaxy A New Outlook on Mental Illnesses: Glial Involvement Beyond the Glue MAPK-Activated Protein Kinases (MKs): Novel Insights and Challenges Novel Insights into the Roles of Rho Kinase in Cancer Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?Molecular Targeting of ERKs/RSK2 Signaling Axis in Cancer Prevention Role of HIPK2 in kidney fibrosis The final link: tapping the power of chemical genetics to connect the molecular and biologic functions of mitotic protein kinases Regulation of calcium channels in smooth muscle: new insights into the role of myosin light chain kinase RSK isoforms in cancer cell invasion and metastasis AMPK as a potential anticancer target - friend or foe?AMP-activated protein kinase: a target for drugs both ancient and modern Mnk kinase pathway: Cellular functions and biological outcomes

P2860

Q21089746-17848CC2-698E-45F8-B3B3-BED7FE27371C Q21090634-8A0E8BBD-6090-462B-9B08-C2F4A17DD0E4 Q21090822-B9F50814-3ED7-447C-930D-D74E11AFE7B3 Q21129334-A889470E-3D2B-4F9B-9814-FAA0EEC3F611 Q21136075-07EF157D-2C7F-458B-9C7B-BCF4EA45B7C2 Q21562345-EE53D396-27BD-4C85-83C4-50DE418179DB Q22252798-1051328F-E365-4141-8B62-93FA586599DF Q24289226-16F9FF8A-DAC5-486A-98C8-E36DF17CF51B Q24292882-58CC7786-AC35-4A02-9790-A6933B9BD779 Q24292901-66D022BD-D831-478E-ADEC-F0D18DADBDD5 Q24293247-EAAC1624-5F0F-4C80-B34C-85A4B47B13C2 Q24297221-8FCE85FC-EF48-4F2D-BCB8-74BFE8CE8649 Q24313261-F37C0190-7BEF-4BD5-BABE-0E78C864A8CD Q24318807-33388DEC-A2F0-486F-9D8E-8705857137E6 Q24322676-181E2264-674C-4239-BA90-BC9CC26D867B Q24336114-B5ECA110-CD09-4E50-B7E5-2C84A38D78C9 Q24337154-819E2C8B-AC1E-497B-8FBD-948FC9490C9E Q24339483-1045D15A-B20D-448F-B996-CE4C7EC30973 Q24610297-9BFC0260-4000-4E97-8BCE-F6BFEB0C1A45 Q24610904-6B75663D-567D-4ABF-83CB-BDEF2BF190A5 Q24617740-5C0D664E-89A4-43FF-AA6D-96BC8649B8D7 Q24626540-B526C839-1876-43E5-99B8-F5FC34C348B2 Q24632768-08090F71-E973-4B40-8818-833CDF158E50 Q24644623-4F0A53C9-4BC9-411F-A5F0-EB01AC5A1E71 Q26741279-C005C258-F4E8-48EC-A690-187F6CD27D88 Q26744743-4660CBCD-5B04-40F7-970C-4B32A1E83A35 Q26747239-52E778FD-264D-429D-9AFC-A57A45708DE6 Q26752327-69BBF16F-791A-49E6-A880-48543AF42339 Q26770756-A6B72F16-1E33-47CB-9B44-DCC01212D47D Q26771339-E317D266-6C5F-401B-A318-2EB09CA032DC Q26771368-F6BCA776-8AFD-45FA-9C72-3191B3CD6C95 Q26775940-F0749453-3017-4128-8010-FAFF9F1EA6CD Q26782527-A3BF234F-ED57-4A83-A884-1BEF7CEF8C1F Q26796620-1D417080-8377-4BBF-97E3-0A2D36490841 Q26823414-871354A7-DA09-429E-9105-8D70F3F0C714 Q26824005-28141D63-B475-43FD-9FD7-AADEB3F5A167 Q26827485-4A50A7D3-4CEE-4B2F-9B9F-4CA798D55A51 Q26829427-D780A3EE-9ED9-4494-820E-A6544AEAD554 Q26864424-A05F17D7-9ADA-41CD-9AAD-0C9AB3D08FA1 Q26865459-84C40E43-02F1-4C26-B160-F1EBA128049E

P2860

The selectivity of protein kinase inhibitors: a further update

http://www.wikidata.org/entity/Q24654622

description

2007 nî lūn-bûn

@nan

2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

The selectivity of protein kinase inhibitors: a further update

@ast

The selectivity of protein kinase inhibitors: a further update

@en

The selectivity of protein kinase inhibitors: a further update

@nl

type

label

The selectivity of protein kinase inhibitors: a further update

@ast

The selectivity of protein kinase inhibitors: a further update

@en

The selectivity of protein kinase inhibitors: a further update

@nl

prefLabel

The selectivity of protein kinase inhibitors: a further update

@ast

The selectivity of protein kinase inhibitors: a further update

@en

The selectivity of protein kinase inhibitors: a further update

@nl

P1433

Q24654622-689819F9-2B8C-446D-A5A9-A8FB76C9C1EA

P1476

Q24654622-D897FB95-821F-4050-BD6D-1E2B50DA025B

P2093

Q24654622-14DD725C-9572-44B4-AF89-27ED3A2F385F

Q24654622-1D020BF5-0310-4A77-945E-B77970B7DD26

Q24654622-3D8ADD5E-CCE4-4D19-A5E5-513F5263F8CF

Q24654622-5A7544C2-1E08-443E-90BD-28C0EE190701

Q24654622-632D5DCD-D1FA-4906-96C4-0260D5A9D342

Q24654622-659E41CB-09B3-46E2-87FE-C30271267A09

Q24654622-9E09ED39-D428-4FD0-A36D-2210BABE3B57

Q24654622-FC09109F-E833-4813-8B9C-3D8AAD976307

P2860

Q24654622-018FF2B9-408F-44B8-84B6-E4545DCE7435

Q24654622-03F952F1-E1D3-4C04-822A-6F504942C29C

Q24654622-0A87707C-0C5B-4CFC-9943-236C0D1323A4

Q24654622-0CAFB8D2-5CED-4C2E-A5BF-B83652C015C7

Q24654622-0D562E31-D19C-418B-B37B-12DD198546EE

Q24654622-0FED8AFF-8372-4EBF-9D13-BE663BAC1823

Q24654622-13DAB6C1-CF19-472A-9DEE-84CC99E2B2A4

Q24654622-1615FB2F-2C15-4EF5-BB8C-78241706E083

Q24654622-16DE3373-1F2C-4A06-811F-EE072358F9F7

Q24654622-1A713B6E-766D-4AB2-8899-55374801A5DE

P304

Q24654622-50452D1E-7860-4141-8966-7E6B897AF8FF

P31

Q24654622-785109C8-4C46-4C8A-98AE-1F262B474DEF

P3181

Q24654622-F2D356FE-8C43-47B0-960D-8141FE9B0443

P356

Q24654622-445A3BB3-D9C0-4556-A486-ED709298B4DC

P407

Q24654622-49DF9B8E-7528-438D-B76F-A2DC0227EA2F

P433

Q24654622-E3A849AD-7BF7-4C58-92D6-D0AAE605E758

P478

Q24654622-5B8DFE38-649F-4CFD-A178-46A240862D30

P50

Q24654622-95985995-CF96-4F79-A03F-00471D67985B

Q24654622-EFC98D43-10C3-419E-8EA6-0F79676F76DA

P577

Q24654622-5BB07597-DB64-4746-B8A9-9971261BA2C4

P698

Q24654622-B7722A04-6E03-45A3-A09D-00A89FCFE855

P921

Q24654622-123F9893-9819-4E8E-BC31-F198A9E7ADC4

Q24654622-5B26CE05-461B-4E7E-8C1A-D4E637A8C80D

P932

Q24654622-E24D91C3-A3CB-4280-9710-B009423A3A9C

P3181

P356

P1433

Biochemical Journal

P1476

The selectivity of protein kinase inhibitors: a further update

@en

P2093

C James Hastie

http://www.w3.org/2001/XMLSchema#string

Hilary McLauchlan

http://www.w3.org/2001/XMLSchema#string

Iva Klevernic

http://www.w3.org/2001/XMLSchema#string

Jenny Bain

http://www.w3.org/2001/XMLSchema#string

Lorna Plater

http://www.w3.org/2001/XMLSchema#string

Matt Elliott

http://www.w3.org/2001/XMLSchema#string

Natalia Shpiro

http://www.w3.org/2001/XMLSchema#string

Philip Cohen

http://www.w3.org/2001/XMLSchema#string

P2860

Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2

Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase)

Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3

MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts

SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site

Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418

Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors

Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast

P304

297-315

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1227356

http://www.w3.org/2001/XMLSchema#string

P356

10.1042/BJ20070797

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

408

http://www.w3.org/2001/XMLSchema#string

P50

Simon J. Arthur

P577

2007-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17850214

http://www.w3.org/2001/XMLSchema#string

P921

Src kinase inhibitor I

P932

2267365

http://www.w3.org/2001/XMLSchema#string